Background: Diabetes mellitus (DM) is a global health epidemic that leads to severe complications such as diabetic nephropathy, retinopathy, neuropathy, and cardiovascular diseases. These complications significantly contribute to morbidity and mortality in diabetic patients. Despite extensive research, the physiological mechanisms underlying the development of these complications remain incompletely understood. The relationship between hyperglycemia, insulin resistance, and vascular dysfunction is critical, but the exact pathways remain an area of active investigation. Objective: This study aims to explore the physiological mechanisms contributing to the development of diabetic complications, with a focus on the molecular and cellular mechanisms involved in endothelial dysfunction, inflammation, oxidative stress, and fibrosis. The goal is to better understand the pathophysiology of these complications to develop more effective therapeutic strategies. Methods: A cohort of 1,000 diabetic patients (Type 1 and Type 2) was assessed for the presence of diabetic complications. Serum and plasma biomarkers associated with inflammation, oxidative stress, and fibrosis were measured, and their relationship with clinical outcomes was analyzed. Additionally, animal models of diabetes were employed to study the underlying molecular pathways involved in endothelial dysfunction and tissue fibrosis. Gene expression analysis and protein assays were performed to assess molecular changes in diabetic tissues. Results: The results demonstrated significant increases in biomarkers of inflammation (e.g., Creactive protein, TNF-α) and oxidative stress (e.g., malondialdehyde, superoxide dismutase) in patients with advanced diabetic complications. In animal models, endothelial dysfunction was shown to correlate with elevated levels of vascular endothelial growth factor (VEGF) and fibrosis markers, including collagen type I and fibronectin. Gene expression analysis revealed significant alterations in key signaling pathways, such as the PI3K/Akt pathway and TGF-β signaling, contributing to vascular remodeling and fibrosis. These findings provide insight into the molecular mechanisms that drive the development of complications in diabetes. Conclusion: The study confirms that chronic hyperglycemia and insulin resistance lead to endothelial dysfunction, increased oxidative stress, and activation of fibrotic pathways, which collectively contribute to the progression of diabetic complications. Targeting these pathways may offer new therapeutic strategies to prevent or mitigate diabetic complications. Future research should focus on the development of targeted interventions aimed at these molecular pathways to reduce the burden of diabetes-related complications.